Skip to main content
. 2023 Mar 17;8:129. doi: 10.1038/s41392-023-01379-7

Fig. 3.

Fig. 3

Non-invasive biomarkers of kidney fibrosis in urine and blood. Blood or urinary biomarkers that are associated with biopsy-proven kidney fibrosis. CCL5 C-C motif chemokine ligand 5, CDH11 Cadherin-11, CXCL C-X-C motif chemokine ligand, DcR2 decoy receptor 2, DKK3 Dickkopf-3, EGF epidermal growth factor, Gal-3 Galectin-3, KIM-1 kidney injury molecule 1, L-FABP liver fatty acid binding protein, LOX lysyl oxidase, MCP-1 monocyte chemoattractant protein-1, MMP-7 matrix metalloproteinase 7, mtDNA mitochondrial DNA, PEDF pigment epithelium-derived factor, PTC-EMP peritubular capillary-endothelial microparticles, SMOC2 Sparc-related modular calcium binding protein-2, suPAR soluble urokinase plasminogen activator receptor, TNC Tenascin-C, VCAM-1 vascular cell adhesion molecule 1, VSIG2 V-set and immunoglobulin domain containing 2